These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 22039318)

  • 41. Chronic hepatitis C infection and insulin resistance: two best friends.
    Abenavoli L; Almasio PL
    Expert Rev Anti Infect Ther; 2011 Aug; 9(8):555-8. PubMed ID: 21819320
    [No Abstract]   [Full Text] [Related]  

  • 42. Molecular mechanisms underlying hepatitis C virus infection-related diabetes.
    Ding Y; Li G; Zhou Z; Deng T
    Metabolism; 2021 Aug; 121():154802. PubMed ID: 34090869
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatitis C virus core protein, lipid droplets and steatosis.
    Roingeard P; Hourioux C
    J Viral Hepat; 2008 Mar; 15(3):157-64. PubMed ID: 18086178
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatitis C virus diversity and hepatic steatosis.
    Roingeard P
    J Viral Hepat; 2013 Feb; 20(2):77-84. PubMed ID: 23301542
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatitis C core protein impairs insulin downstream signalling and regulatory role of IGFBP-1 expression.
    Alberstein M; Zornitzki T; Zick Y; Knobler H
    J Viral Hepat; 2012 Jan; 19(1):65-71. PubMed ID: 22187946
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Insulin resistance and liver injury in hepatitis C is not associated with virus-specific changes in adipocytokines.
    Cua IH; Hui JM; Bandara P; Kench JG; Farrell GC; McCaughan GW; George J
    Hepatology; 2007 Jul; 46(1):66-73. PubMed ID: 17596870
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Metabolic syndrome in patients with chronic hepatitis C genotype 1].
    Baĭzhanova ZhZh; Ignatova TM; Nekrasova TP; Abdurakhmanov DT
    Vestn Ross Akad Med Nauk; 2011; (1):3-7. PubMed ID: 21400720
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C.
    Lo Iacono O; Venezia G; Petta S; Mineo C; De Lisi S; Di Marco V; Rodolico V; Amato M; Ferraro D; Giordano C; Almasio PL; Craxí A
    Aliment Pharmacol Ther; 2007 May; 25(10):1181-91. PubMed ID: 17451564
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metabolic aspects of hepatitis C viral infection: steatohepatitis resembling but distinct from NASH.
    Koike K; Moriya K
    J Gastroenterol; 2005 Apr; 40(4):329-36. PubMed ID: 15868369
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatitis C virus, diabetes and steatosis: clinical evidence in favor of a linkage and role of genotypes.
    Mihm S
    Dig Dis; 2010; 28(1):280-4. PubMed ID: 20460924
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatic steatosis and hepatitis C: Still unhappy bedfellows?
    Hwang SJ; Lee SD
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():96-101. PubMed ID: 21199519
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3.
    Rubbia-Brandt L; Quadri R; Abid K; Giostra E; Malé PJ; Mentha G; Spahr L; Zarski JP; Borisch B; Hadengue A; Negro F
    J Hepatol; 2000 Jul; 33(1):106-15. PubMed ID: 10905593
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum leptin and ghrelin in chronic hepatitis C patients with steatosis.
    Pavlidis C; Panoutsopoulos GI; Tiniakos D; Koutsounas S; Vlachogiannakos J; Zouboulis-Vafiadis I
    World J Gastroenterol; 2011 Dec; 17(46):5097-104. PubMed ID: 22171144
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3.
    Abenavoli L; Masarone M; Peta V; Milic N; Kobyliak N; Rouabhia S; Persico M
    World J Gastroenterol; 2014 Nov; 20(41):15233-40. PubMed ID: 25386071
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vivo analysis at the cellular level reveals similar steatosis induction in both hepatitis C virus genotype 1 and 3 infections.
    Campana B; Calabrese D; Matter MS; Terracciano LM; Wieland SF; Heim MH
    J Viral Hepat; 2018 Mar; 25(3):262-271. PubMed ID: 29086446
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The interaction of metabolic factors with HCV infection: does it matter?
    Bugianesi E; Salamone F; Negro F
    J Hepatol; 2012; 56 Suppl 1():S56-65. PubMed ID: 22300466
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Correlation of serum adiponectin levels and hepatic steatosis in hepatitis C virus genotype 1 infection.
    Kara B; Gunesacar R; Doran F; Kara IO; Akkiz H
    Adv Ther; 2007; 24(5):972-82. PubMed ID: 18029322
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease.
    Lonardo A; Adinolfi LE; Loria P; Carulli N; Ruggiero G; Day CP
    Gastroenterology; 2004 Feb; 126(2):586-97. PubMed ID: 14762795
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The ratio of insulin-like growth factor-I/insulin-like growth factor-binding protein-3 in sera of patients with hepatitis C virus-related chronic liver disease as a predictive marker of insulin resistance.
    Himoto T; Tani J; Miyoshi H; Yoneyama H; Mori H; Inukai M; Masugata H; Goda F; Senda S; Haba R; Masaki T
    Nutr Res; 2013 Jan; 33(1):27-33. PubMed ID: 23351407
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chronic hepatitis B associated with hepatic steatosis, insulin resistance, necroinflammation and fibrosis.
    Yilmaz B; Koklu S; Buyukbayram H; Yalçin K; Korkmaz U; Posul E; Can G; Kurt M
    Afr Health Sci; 2015 Sep; 15(3):714-8. PubMed ID: 26957957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.